University of Tasmania
Browse

File(s) under permanent embargo

Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina

chapter
posted on 2023-05-22, 22:25 authored by Hung, SS, Li, F, Wang, J-H, Anna KingAnna King, Bui, BV, Guei-Sheung LiuGuei-Sheung Liu
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) is used by some bacteria and most archaea to protect against viral phage intrusion and has recently been adapted to allow for efficient editing of the mammalian genome. Whilst CRISPR/Cas-based technology has been used to modify genes in mammalian cells in vitro, delivery of CRISPR/Cas system into mammalian tissue and/or organs is more difficult and often requires additional vectors. With the use of adeno-associated virus (AAV) gene delivery system, active CRISPR/Cas enzyme can be maintained for an extended period of time and enable efficient editing of genome in the retina in vivo. Herein we outline the method to edit the genome in mouse retina using a dual AAV vector-mediated CRISPR/Cas9 system.

History

Publication title

Retinal Gene Therapy: Methods and Protocols

Editors

CJF Boon, J Wijnholds

Pagination

113-133

ISBN

978-1-4939-7521-1

Department/School

Menzies Institute for Medical Research

Publisher

Humana Press

Place of publication

United States

Extent

27

Rights statement

Copyright 2018 Springer Science+Business Media LLC

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC